Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howell F Moffett

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Genome Biology|August 2, 2007
A small RNA makes a Bic differenceHowell F Moffett, Carl D Novina
The Journal of Allergy and Clinical Immunology|February 14, 2008
Not miR-ly small RNAs: big potential for microRNAs in therapyTara M Love, Howell F Moffett, Carl D Novina
Science Immunology|May 19, 2019
B cells engineered to express pathogen-specific antibodies protect against infectionHowell F Moffett, Carson K Harms, Kristin S Fitzpatrick, et al.
Journal of Virology|July 29, 2004
Beyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4(+) T cellsPhilip J Norris, Howell F Moffett, Otto O Yang, et al.
Frontiers in Molecular Medicine|August 1, 2024
Safety switch optimization enhances antibody-mediated elimination of CAR T cellsTamer B Shabaneh, Howell F Moffett, Sylvia M Stull, et al.
Plos One|March 17, 2011
MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cellsShuqiang Li, Howell F Moffett, Jun Lu, et al.
AIDS Research and Human Retroviruses|May 1, 2004
Fine specificity and cross-clade reactivity of HIV type 1 Gag-specific CD4+ T cellsPhilip J Norris, Howell F Moffett, Christian Brander, et al.
Nature Nanotechnology|April 19, 2017
In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriersTyrel T Smith, Sirkka B Stephan, Howell F Moffett, et al.
The Journal of Clinical Investigation|April 25, 2017
Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumorsTyrel T Smith, Howell F Moffett, Sirkka B Stephan, et al.
Molecular Immunology|October 12, 2005
Antagonism of HIV-specific CD4+ T cells by C-terminal truncation of a minimum epitopePhilip J Norris, Jennifer D Stone, Nadezhda Anikeeva, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Genome Biology|August 2, 2007
A small RNA makes a Bic differenceHowell F Moffett, Carl D Novina
The Journal of Allergy and Clinical Immunology|February 14, 2008
Not miR-ly small RNAs: big potential for microRNAs in therapyTara M Love, Howell F Moffett, Carl D Novina
Science Immunology|May 19, 2019
B cells engineered to express pathogen-specific antibodies protect against infectionHowell F Moffett, Carson K Harms, Kristin S Fitzpatrick, et al.
Journal of Virology|July 29, 2004
Beyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4(+) T cellsPhilip J Norris, Howell F Moffett, Otto O Yang, et al.
Frontiers in Molecular Medicine|August 1, 2024
Safety switch optimization enhances antibody-mediated elimination of CAR T cellsTamer B Shabaneh, Howell F Moffett, Sylvia M Stull, et al.
Plos One|March 17, 2011
MicroRNA expression profiling identifies activated B cell status in chronic lymphocytic leukemia cellsShuqiang Li, Howell F Moffett, Jun Lu, et al.
AIDS Research and Human Retroviruses|May 1, 2004
Fine specificity and cross-clade reactivity of HIV type 1 Gag-specific CD4+ T cellsPhilip J Norris, Howell F Moffett, Christian Brander, et al.
Nature Nanotechnology|April 19, 2017
In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriersTyrel T Smith, Sirkka B Stephan, Howell F Moffett, et al.
The Journal of Clinical Investigation|April 25, 2017
Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumorsTyrel T Smith, Howell F Moffett, Sirkka B Stephan, et al.
Molecular Immunology|October 12, 2005
Antagonism of HIV-specific CD4+ T cells by C-terminal truncation of a minimum epitopePhilip J Norris, Jennifer D Stone, Nadezhda Anikeeva, et al.
Pageof 2